Literature DB >> 31773458

Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).

Francesco Amato1, Giulia Bicchierai2, Donatello Cirone3, Catherine Depretto4, Federica Di Naro5, Ermanno Vanzi5, Gianfranco Scaperrotta4, Tommaso Vincenzo Bartolotta1, Vittorio Miele6, Jacopo Nori5.   

Abstract

The aim of our study was to assess the performance of contrast-enhanced digital mammography (CEDM) in the preoperative loco-regional staging of invasive lobular carcinoma (ILC) patients, about the valuation of the extension of disease and in measurement of lesions. Then, we selected retrospectively, among the 1500 patients underwent to CEDM at the Breast Diagnostics Department of the Careggi University Hospital of Florence and the National Cancer Institute of Milan from September 2016 to November 2018, 31 women (mean age 57.1 aa; range 41-78 aa) with a definitive histological diagnosis of ILC. CEDM has proved to be a promising imaging technique, being characterized by a sensitivity of 100% in the detection of the index lesion, and of 84.2% in identifying any adjunctive lesions: It was the presence of a non-mass enhancement (NME) to lower the sensitivity of the technique (25% vs. 100% for mass-like enhancements or a mass closely associated with a NME). Specificity in the characterization of additional lesions was 66.7%, and the diagnosis of the extension of disease was correct in 77.4% of cases: NME also led to a decrease in diagnostic accuracy in the evaluation of disease extension up to 40% versus 85% for masses and 80% for masses associated with NME (M/NME). Moreover, in 12/31 (38.7%), CEDM allowed to correctly identify lesions not shown by mammography + ultrasonography + tomosynthesis: In the half of these (6/12), there was a multicentricity, thus allowing an adequate surgical planning change. CEDM was also very accurate in analyzing the maximum diameter of the masses, while it was much less reliable in the case of the M/NME and pure NME. In conclusion, CEDM is a new promising imaging technique in the loco-regional preoperative staging and in the evaluation of disease extension for ILC, especially in case of mass enhancement lesions.

Entities:  

Keywords:  Breast; Breast cancer staging; Contrast-enhanced digital mammography; Contrast-enhanced spectral mammography; Invasive lobular breast cancer

Mesh:

Substances:

Year:  2019        PMID: 31773458     DOI: 10.1007/s11547-019-01116-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  45 in total

Review 1.  Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.

Authors:  Mathew Thomas; Erinn Downs Kelly; Jame Abraham; Megan Kruse
Journal:  Semin Oncol       Date:  2019-06-17       Impact factor: 4.929

2.  Role of DCE-MR in predicting breast cancer subtypes.

Authors:  Marco Macchini; Martina Ponziani; Andrea Prochowski Iamurri; Mirco Pistelli; Mariagrazia De Lisa; Rossana Berardi; Gian Marco Giuseppetti
Journal:  Radiol Med       Date:  2018-06-05       Impact factor: 3.469

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.

Authors:  Stefania Montemezzi; Carlo Cavedon; Lucia Camera; Gabriele Meliadò; Francesca Caumo; Ilaria Baglio; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-12-15       Impact factor: 3.469

5.  Role of contrast-enhanced spectral mammography in the post biopsy management of B3 lesions: Preliminary results.

Authors:  Giulia Bicchierai; Jacopo Nori; Diego De Benedetto; Cecilia Boeri; Ermanno Vanzi; Simonetta Bianchi; Maninderpal Kaur Gill; Donatello Cirone; Vittorio Miele
Journal:  Tumori       Date:  2018-12-17       Impact factor: 2.098

6.  Mammographic features of 455 invasive lobular carcinomas.

Authors:  M Le Gal; L Ollivier; B Asselain; M Meunier; M Laurent; P Vielh; S Neuenschwander
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

7.  Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.

Authors:  Rachel F Brem; Marina Ioffe; Jocelyn A Rapelyea; Kristen G Yost; Jean M Weigert; Margaret L Bertrand; Lillian H Stern
Journal:  AJR Am J Roentgenol       Date:  2009-02       Impact factor: 3.959

8.  Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study.

Authors:  Anne-Julie Carin; Sébastien Molière; Victor Gabriele; Massimo Lodi; Nicolas Thiébaut; Karl Neuberger; Carole Mathelin
Journal:  World J Surg Oncol       Date:  2017-07-14       Impact factor: 2.754

9.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Authors:  Grazia Arpino; Valerie J Bardou; Gary M Clark; Richard M Elledge
Journal:  Breast Cancer Res       Date:  2004-02-17       Impact factor: 6.466

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

View more
  4 in total

Review 1.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

2.  Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?

Authors:  Giulia Bicchierai; Francesco Amato; Bianca Vanzi; Diego De Benedetto; Cecilia Boeri; Ermanno Vanzi; Federica Di Naro; Simonetta Bianchi; Donatello Cirone; Diletta Cozzi; Vittorio Miele; Jacopo Nori
Journal:  Breast       Date:  2020-08-21       Impact factor: 4.380

Review 3.  How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature.

Authors:  Federica Vasselli; Alessandra Fabi; Francesca Romana Ferranti; Maddalena Barba; Claudio Botti; Antonello Vidiri; Silvia Tommasin
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

4.  Invasive lobular carcinoma mammographic findings: correlation with age, breast composition, and tumour size.

Authors:  Corrado Tagliati; Federico Cerimele; Antonietta Di Martino; Fabrizio Capone; Marialuisa Di Matteo; Nevia Caputo; Gabriella Lucidi Pressanti; Ying Mingliang; Silvia Baldassarre; Andrea Giovagnoni; Gian Marco Giuseppetti
Journal:  Pol J Radiol       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.